癌症的分子病理学:从泛基因组学到后基因组学
本文为《Journal of Pathology》2018年年度综述专辑的导言,总结泛基因组方法在癌症分类、靶向治疗选择和进展评估中的应用,并综述循环游离肿瘤DNA、胚系易感性、表观遗传与DNA修复、蛋白质组学、计算病理学、细胞应激反应和微生物组等后基因组领域。
要点
- 泛基因组分析已用于癌症分类、靶向治疗选择和进展评估
- 后基因组领域包括循环游离肿瘤DNA和胚系癌症易感性分析
- 表观遗传、DNA修复、蛋白质组学、计算病理学和微生物组受到关注
核心结论
- 泛基因组方法推动了癌症分类、靶向治疗选择和进展评估的基因组学革新。
- 后基因组领域的多样进展正在 informing 并改变癌症病理学实践。
研究设计与样本
- 本文为《Journal of Pathology》2018年年度综述专辑的导言,汇总多篇综述。
主要发现
- 过去十年通过多项国家和国际努力已全面编目多数主要癌症类型的癌症基因组学。
- 癌症亚型划分得到细化,对关键癌症驱动因素及其可靶向脆弱性的理解大幅增长。
- 后基因组领域综述涵盖循环游离肿瘤DNA、胚系易感性、表观遗传、DNA修复、蛋白质组学、计算病理学、细胞应激反应和微生物组。
临床怎么用
- 癌症病理学实践正因从多样人类生物标本中获取的生物学信息而得到 informing 和转变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As the cancer genomics of most major cancer types have been comprehensively catalogued over the past decade through a variety of national and international efforts, the delineation of cancer subtypes has been refined, and our understanding of critical cancer drivers and of the potentially targetable vulnerabilities that they create has grown tremendously. The 2018 Annual Review Issue of the Journal of Pathology provides in-depth assessments of how these pan-genomic approaches have enabled advances in cancer classification, targeted therapy selection, and assessment of cancer progression, all of which are now genomically informed, using several cancer types as examples. Beyond these areas of by now conventional pan-genomic tumour analysis, there are also reviews of diverse 'post-genomic' areas, such as the analysis of circulating free tumour DNA in plasma, concurrent germline cancer predisposition profiling in the setting of apparently sporadic cancer, genetic alterations in epigenetic control and DNA repair, proteomics of tumour heterogeneity, computational pathology, and the roles of the cellular stress response and the microbiome in human cancers. As we are able to derive more and more biologically useful information from diverse human biospecimens, these many advances are informing and transforming the practice of cancer pathology. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
- Huntsman DG, Ladanyi M. The molecular pathology of cancer: from pan-genomics to post-genomics. J Pathol. 2018. PMID: 29436707. doi:10.1002/path.5057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。